title: Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial.
authors.forename: Hallvard
authors.initials: H
authors.lastname: Holdaas
authors.forename: Bengt
authors.initials: B
authors.lastname: Fellström
authors.forename: Alan G
authors.initials: AG
authors.lastname: Jardine
mesh_terms: D002318:Cardiovascular Diseases / Q000628:therapy; D002986:Clinical Trials as Topic; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use*; D000077340:Fluvastatin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000175:diagnosis* / Q000628:therapy*; D007211:Indoles / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000628:therapy; D016030:Kidney Transplantation; D011786:Quality Control; D012307:Risk Factors
chemical_list: D005229:Fatty Acids, Monounsaturated; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D000077340:Fluvastatin